You are here

Crohn’s Disease Market Set to Record Exponential Growth by 2021 – Persistence Market Research – Medgadget (blog)

Crohn’s Disease Market Set to Record Exponential Growth by 2021 – Persistence Market ResearchMedgadget (blog)Crohn’s disease refers to long term inflammatory bowel disease, which causes inflammation of the lining of the digestive tract. It affects the large and small intestine and is generally diagnosed in persons within the age group of 20-29. It can have … FULL ARTICLE:

Read More

High-dose mesalamine effective as alternative induction therapy for mild-to-moderate Crohn’s disease

Among different induction therapies for mild-to-moderate Crohn’s disease, corticosteroids and high-dose budesonide were both effective, and high-dose mesalamine was an effective alternative, according to the results of a Bayesian network meta-analysis.“Physicians and patients have many options in treating mild to moderately active Crohn’s disease,” Gilaad G. Kaplan, MD, MPH, from the departments of medicine and community health sciences at University of Calgary in Canada, told Healio Gastroenterology. “While corticosteroids are effective in treating Crohn’s disease, patients often prefer to avoid prednisone due to potential systemic toxicities.” FULL ARTICLE:

Read More

Rosacea may be tied to increased risk for inflammatory bowel disease

There was an increased risk for inflammatory bowel disease in patients with rosacea, according to study results published in the Journal of the American Academy of Dermatology.Researchers in Taiwan used the Taiwanese National Health Insurance Research Database to identify 89,356 patients with rosacea and 178,712 matched patients without rosacea (reference cohort) between 1997 and 2013 for analysis. The two cohorts were compared for cumulative incidences of inflammatory bowel disease (IBD). FULL ARTICLE:

Read More

Childhood IBD risk not affected by maternal infections, antibiotic use during pregnancy

Children born to mothers who acquired an infection requiring antibiotics during pregnancy do not have an increased risk for developing inflammatory bowel disease, according to the results of a Canadian population-based study.This finding led investigators to suggest that other events affecting the gut microbiome later in childhood may have a more important impact on a child’s risk for IBD. FULL ARTICLE:

Read More
<< Go Back